Klotho Neurosciences (KLTO) Stock Price, News & Analysis

Company Overview

Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Key Stats

• Today's Range: $1.40 to $1.56
• 50-Day Range: $0.13 to $2.01
• 52-Week Range: $0.11 to $5.95
• Volume: 3.68 million shs
• Average Volume: 30.97 million shs
• Market Capitalization: $48.74 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KLTO Stock Analysis - Frequently Asked Questions

How have KLTO shares performed this year?

Klotho Neurosciences' stock was trading at $0.4850 at the beginning of 2025. Since then, KLTO shares have increased by 209.3% and is now trading at $1.50.
View the best growth stocks for 2025 here.

How were Klotho Neurosciences' earnings last quarter?

Klotho Neurosciences, Inc. (NASDAQ:KLTO) posted its quarterly earnings data on Thursday, May, 15th. The company reported ($0.08) EPS for the quarter.

How do I buy shares of Klotho Neurosciences?

Shares of KLTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/15/2025
• Today: 6/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:KLTO
• Previous Symbol: NASDAQ:KLTO
• CIK: 1907223
• Web: www.klothoneuro.com
• Phone: (833) 931-6330
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.36)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.15 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -1,779.01%
• Return on Assets: -275.01%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.29
• Quick Ratio: 0.29

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.04 per share
• Price / Book: 37.50

Miscellaneous

• Outstanding Shares: 32,490,000
• Free Float: 23,818,000
• Market Cap: $48.74 million
• Optionable: N/A
• Beta: 0.18